Back
Protalix BioTherapeutics Stock Price Chart
Sponsored
PLX
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
54
PLX
Protalix BioTherapeutics
Last Price:
1.15
Seasonality Move:
79.27%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.
Protalix BioTherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.06 | Buy |
20-day SMA: | 1 | Buy |
50-day SMA: | 1.04 | Buy |
200-day SMA: | 1.29 | Sell |
8-day EMA: | 1.06 | Buy |
20-day EMA: | 1.03 | Buy |
50-day EMA: | 1.05 | Buy |
200-day EMA: | 1.25 | Sell |
Protalix BioTherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 59.72 | Buy |
Chaikin Money Flow: | -172648 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.93 - 1.05) | Buy |
Bollinger Bands (100): | (1.01 - 1.19) | Sell |
Protalix BioTherapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.09 while PLX 8-day simple moving average is 1.06, which is a Buy signal.
- The stock price of PLX is 1.09 while Protalix BioTherapeutics 20-day SMA is 1.00, which makes it a Buy.
- Protalix BioTherapeutics 50-day simple moving average is 1.04 while PLX share price is 1.09, making it a Buy technically.
- PLX stock price is 1.09 and Protalix BioTherapeutics 200-day simple moving average is 1.29, creating a Sell signal.
PLX Technical Analysis vs Fundamental Analysis
Buy
54
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a Buy
The current Protalix BioTherapeutics [PLX] share price is $1.09. The Score for PLX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
80.16M
Price in USD:
1.09
Share Volume:
172.65K
Protalix BioTherapeutics 52-Week Range
52-Week High:
1.90
52-Week Low:
0.82
Buy
54
Protalix BioTherapeutics (PLX)
is a Buy
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?
The Protalix BioTherapeutics stock price is 1.09 USD today. -
Will PLX stock go up or go down?
Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protalix BioTherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is not overvalued.
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.09 while PLX 8-day exponential moving average is 1.06, which is a Buy signal.
- The stock price of PLX is 1.09 while Protalix BioTherapeutics 20-day EMA is 1.03, which makes it a Buy.
- Protalix BioTherapeutics 50-day exponential moving average is 1.05 while PLX share price is 1.09, making it a Buy technically.
- PLX stock price is 1.09 and Protalix BioTherapeutics 200-day simple moving average is 1.25, creating a Sell signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
- PLX Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Protalix BioTherapeutics is a Buy
- Protalix BioTherapeutics Relative Strength Index (RSI) is 59.72, which suggest Protalix BioTherapeutics is overbought
- The Bollinger Bands (25) for Protalix BioTherapeutics is (0.93 - 1.05), which suggest Protalix BioTherapeutics is a Sell
- The Bollinger Bands (100) for Protalix BioTherapeutics is (1.01 - 1.19), which suggest Protalix BioTherapeutics is a Sell
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.